{"id":"W2061612454","doi":"10.1177/1753465810371107","title":"Emerging therapies in cystic fibrosis","year":2010,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bayer Canada; Gilead Sciences","keywords":"Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Clinical trial; Life expectancy; Disease; Targeted therapy; Immunology; Intensive care medicine; Bioinformatics; Internal medicine; Population","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007523863,0.0009214794,0.002621526,0.001308656,0.0000989749,0.00006163381,0.0006550363,0.0003631953,0.0004567951],"category_scores_gemma":[0.0006563521,0.0007397236,0.0005918113,0.001471679,0.0005480634,0.000479067,0.0001634298,0.001915923,0.0001416266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004938975,"about_ca_system_score_gemma":0.001351516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005426697,"about_ca_topic_score_gemma":0.00006689899,"domain_scores_codex":[0.9948106,0.0006217575,0.001425843,0.001142206,0.0009147796,0.001084782],"domain_scores_gemma":[0.9964627,0.001053321,0.0004148145,0.001364886,0.00009363083,0.0006106435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004101637,0.0003113591,0.001118368,0.01868049,0.00005014252,0.0003876712,0.00006359919,0.00001493243,0.00001173195,0.0002027923,0.00001028529,0.9787385],"study_design_scores_gemma":[0.001133082,0.0001826205,0.0006790364,0.02113679,0.0003632173,0.000009159848,0.00005950409,0.00002170153,0.000002262715,0.001254456,0.9745064,0.0006517768],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001539337,0.9962355,0.00008786439,0.00005496251,0.000366207,0.002437767,0.0001151893,0.0001207094,0.0004277915],"genre_scores_gemma":[0.0002802599,0.9962359,0.0006327428,0.0003382951,0.0003233675,0.001756982,0.00007115332,0.000199831,0.0001614393],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9780867,"threshold_uncertainty_score":0.9995054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04226880032122836,"score_gpt":0.4069944207173359,"score_spread":0.3647256203961075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}